Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The facility is over 79,000 square feet and is equipped with packaging lines
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The company is addressing these observations
India has a pivotal role in eliminating TB
Integration of modern and traditional medicine to facilitate the illness to wellness journey
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
Subscribe To Our Newsletter & Stay Updated
